+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Smoking Cessation and Nicotine De-addiction Market 2021-2025

  • ID: 4990981
  • Report
  • November 2021
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Imperial Brands Plc
  • Japan Tobacco Inc.
  • Johnson and Johnson Inc.
  • JUUL Labs Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the smoking cessation and nicotine de-addiction market and it is poised to grow by $ 18.01 bn during 2021-2025, progressing at a CAGR of 11.59% during the forecast period. The report on the smoking cessation and nicotine de-addiction market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by new product launches and increasing number of people trying to quit smoking.

The smoking cessation and nicotine de-addiction market analysis includes the product segment and geographic landscape.

The smoking cessation and nicotine de-addiction market is segmented as below:


By Product

  • e-cigarette
  • NRT
  • drug therapy

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • MEA

This study identifies the growing health awareness among consumers about harmful effects of cigars as one of the prime reasons driving the smoking cessation and nicotine de-addiction market growth during the next few years.

The report on smoking cessation and nicotine de-addiction market covers the following areas:

  • Smoking cessation and nicotine de-addiction market sizing
  • Smoking cessation and nicotine de-addiction market forecast
  • Smoking cessation and nicotine de-addiction market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading smoking cessation and nicotine de-addiction market vendors that include British American Tobacco Plc, Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Inc., JUUL Labs Inc., Pfizer Inc., and Philip Morris International Inc. Also, the smoking cessation and nicotine de-addiction market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Imperial Brands Plc
  • Japan Tobacco Inc.
  • Johnson and Johnson Inc.
  • JUUL Labs Inc.

Executive Summary

  • Market overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • E-cigarette - Market size and forecast 2020-2025
  • NRT - Market size and forecast 2020-2025
  • Drug therapy - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • APAC - Market size and forecast 2020-2025
  • South America - Market size and forecast 2020-2025
  • MEA - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity By Geographical Landscape
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • British American Tobacco Plc
  • Cipla Inc.
  • Dr. Reddys Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Imperial Brands Plc
  • Japan Tobacco Inc.
  • Johnson and Johnson Inc.
  • JUUL Labs Inc.
  • Pfizer Inc.
  • Philip Morris International Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits

  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • E-cigarette - Market size and forecast 2020-2025 ($ million)
  • E-cigarette - Year-over-year growth 2020-2025 (%)
  • NRT - Market size and forecast 2020-2025 ($ million)
  • NRT - Year-over-year growth 2020-2025 (%)
  • Drug therapy - Market size and forecast 2020-2025 ($ million)
  • Drug therapy - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share By Geographical Landscape 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • APAC - Market size and forecast 2020-2025 ($ million)
  • APAC - Year-over-year growth 2020-2025 (%)
  • South America - Market size and forecast 2020-2025 ($ million)
  • South America - Year-over-year growth 2020-2025 (%)
  • MEA - Market size and forecast 2020-2025 ($ million)
  • MEA - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity By Geographical Landscape ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • British American Tobacco Plc - Overview
  • British American Tobacco Plc - Business segments
  • British American Tobacco Plc - Key offerings
  • British American Tobacco Plc - Key customers
  • British American Tobacco Plc - Segment focus
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Key customers
  • Cipla Inc. - Segment focus
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Key customers
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Imperial Brands Plc - Overview
  • Imperial Brands Plc - Business segments
  • Imperial Brands Plc - Key offerings
  • Imperial Brands Plc - Key customers
  • Imperial Brands Plc - Segment focus
  • Japan Tobacco Inc. - Overview
  • Japan Tobacco Inc. - Business segments
  • Japan Tobacco Inc. - Key offerings
  • Japan Tobacco Inc. - Key customers
  • Japan Tobacco Inc. - Segment focus
  • Johnson and Johnson Inc. - Overview
  • Johnson and Johnson Inc. - Business segments
  • Johnson and Johnson Inc. - Key offerings
  • Johnson and Johnson Inc. - Key customers
  • Johnson and Johnson Inc. - Segment focus
  • JUUL Labs Inc. - Overview
  • JUUL Labs Inc. - Product and service
  • JUUL Labs Inc. - Key offerings
  • JUUL Labs Inc. - Key customers
  • JUUL Labs Inc. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Philip Morris International Inc. - Overview
  • Philip Morris International Inc. - Business segments
  • Philip Morris International Inc. - Key offerings
  • Philip Morris International Inc. - Key customers
  • Philip Morris International Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Imperial Brands Plc
  • Japan Tobacco Inc.
  • Johnson and Johnson Inc.
  • JUUL Labs Inc.
The publisher recognizes the following companies as the key players in the global smoking cessation and nicotine de-addiction market: British American Tobacco Plc, Cipla Inc., Dr. Reddys Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco Inc., Johnson and Johnson Inc., JUUL Labs Inc., Pfizer Inc., and Philip Morris International Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing health awareness among consumers about harmful effects of cigars.`

According to the report, one of the major drivers for this market is the new product launch.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • British American Tobacco Plc
  • Cipla Inc.
  • Dr. Reddys Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Imperial Brands Plc
  • Japan Tobacco Inc.
  • Johnson and Johnson Inc.
  • JUUL Labs Inc.
  • Pfizer Inc.
  • Philip Morris International Inc.
Note: Product cover images may vary from those shown